KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to $6.9 million.

  • Pacira BioSciences' Depreciation and Depletion rose 1500.0% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year increase of 7872.34%. This contributed to the annual value of $21.5 million for FY2024, which is 1748.63% up from last year.
  • Per Pacira BioSciences' latest filing, its Depreciation and Depletion stood at $6.9 million for Q3 2025, which was up 1500.0% from $13.0 million recorded in Q2 2025.
  • Pacira BioSciences' Depreciation and Depletion's 5-year high stood at $16.2 million during Q4 2022, with a 5-year trough of $2.9 million in Q1 2021.
  • For the 5-year period, Pacira BioSciences' Depreciation and Depletion averaged around $6.1 million, with its median value being $5.4 million (2021).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 20000.0% in 2022, then plummeted by 7407.41% in 2023.
  • Over the past 5 years, Pacira BioSciences' Depreciation and Depletion (Quarter) stood at $5.4 million in 2021, then surged by 200.0% to $16.2 million in 2022, then plummeted by 74.07% to $4.2 million in 2023, then surged by 64.29% to $6.9 million in 2024, then changed by 0.0% to $6.9 million in 2025.
  • Its Depreciation and Depletion was $6.9 million in Q3 2025, compared to $13.0 million in Q2 2025 and $6.8 million in Q1 2025.